IJMS | Free Full-Text | Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells | HTML
YM155 (Sepantronium Bromide) | ≥99%(HPLC) | Selleck | Survivin inhibitor
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma | Oncotarget
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
JCM | Free Full-Text | Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma | HTML
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway | Scientific Reports
Survivin and YM155: How faithful is the liaison? - ScienceDirect
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair - ScienceDirect
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice | Oncotarget
YM155 affects the expression of XIAP as well as survivin in pancreatic... | Download Scientific Diagram
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
